14:27:22 EDT Thu 28 Oct 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:SAVA - CASSAVA SCIENCES INC - https://www.cassavasciences.com/14:27:22 EDT
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
SAVA - Q0.145.52·45.640.145.585+0.9752.21,673.675,02318,78344.85  46.023  43.72146.16  6.7014:07:58Oct 2515 min RT 2¢

Recent Trades - Last 10 of 18783
Time ETExPriceChangeVolume
14:07:58Q45.58170.971725
14:07:57Q45.600.9910
14:07:53Q45.631.0250
14:07:53Q45.651.0450
14:07:53Q45.611.003
14:07:53Q45.631.0277
14:07:53Q45.641.033
14:07:53Q45.611.004
14:07:53Q45.621.013
14:07:53Q45.641.037

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent BulletinsNews ReleasesIn The NewsOther
Date ETSymbolTypeHeadline
2021-10-25 23:01U:SAVANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadline - SAVA
2021-10-25 16:48U:SAVANews ReleaseCASSAVA SCIENCES 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Cassava Sciences, Inc. - SAVA
2021-10-25 13:42U:SAVANews ReleaseSAVA FINAL DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 26 Deadline in Securities Class Action - SAVA
2021-10-23 18:00U:SAVANews ReleaseSAVA INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Cassava Sciences, Inc.
2021-10-22 22:50U:SAVANews ReleaseCASSAVA SCIENCES 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Cassava Sciences, Inc. - SAVA
2021-10-22 11:30U:SAVANews ReleaseSAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit
2021-10-20 15:09U:SAVANews ReleaseROSEN, RESPECTED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors With Losses to Secure Counsel Before Important October 26 Deadline in Securities Class Action - SAVA
2021-10-20 12:15U:SAVANews ReleaseINVESTOR ALERT: OCTOBER 26, 2021 CASSAVA SCIENCES, INC. (NASDAQ: SAVA) CLASS ACTION LAWSUIT DEADLINE REMINDER: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Cassava Sc
2021-10-16 01:00U:SAVANews Release(SAVA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Cassava Class Action Lawsuit
2021-10-15 20:49U:SAVANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadline - SAVA
2021-10-13 12:00U:SAVANews ReleaseSAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit
2021-10-10 17:40U:SAVANews ReleaseImportant Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Cassava Sciences, Inc. Investors of Securities Fraud Class Action Lawsuit
2021-10-07 18:51U:SAVANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadline - SAVA
2021-10-06 08:30U:SAVANews ReleaseCassava Sciences Initiates a Phase 3 Efficacy Trial of Simufilam for the Treatment of Patients with Alzheimer ’s Disease
2021-10-05 23:00U:SAVANews ReleaseROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors with Losses to Secure Counsel Before Important October 26 Deadline in Securities Class Action - SAVA